Genetics of Cancer: Mechanisms, Mutations, and Cellular Pathways

Genetics of Cancer

Introduction to Cancer Genetics

Cancer is a group of genetic disorders characterized by the uncontrolled and inappropriate growth of cells. It can affect nearly all organ systems and cell types, and is the second leading cause of death in the United States. The study of cancer genetics focuses on the mutations and cellular mechanisms that drive the transformation of normal cells into malignant ones.

• Cancer incidence: Over 2 million new cases and over 600,000 deaths annually in the US.

• Leading causes of death: Cancer is second only to heart disease.

• Advancements: Since the 1980s, cancer deaths have decreased by more than 25% due to improved screening, research, and treatment.

What is Cancer?

Definition and Types of Tumors

Cancer arises from the uncontrolled and inappropriate growth of cells. Tumors can be classified as:

• Benign tumor: Remains localized and is usually not dangerous unless it compresses vital organs.

• Malignant tumor: Invades surrounding tissues and can spread to other parts of the body.

• Metastatic tumor: Forms when cancer cells travel from the primary site to colonize new locations.

Properties of Cancer Cells

Cancer cells share several hallmark properties that distinguish them from normal cells:

• Self-sufficiency in growth signals

• Insensitivity to anti-growth signals

• Evading apoptosis (programmed cell death)

• Sustained angiogenesis (formation of new blood vessels)

• Tissue invasion and metastasis

• Limitless replicative potential (immortalization)

Metastasis

Metastasis is the process by which cancer cells spread from the primary tumor to distant sites in the body, often leading to secondary tumors. This is responsible for approximately 90% of cancer deaths.

• Steps in metastasis: Local invasion, intravasation, survival in circulation, arrest in distant organs, extravasation, micrometastasis, and macrometastatic growth.

Genetic Basis of Cancer

Somatic vs. Hereditary Mutations

Most cancers are caused by mutations in the genome. These mutations can be:

• Somatic mutations: Occur in non-germline cells; account for ~90% of cancers (sporadic).

• Germline mutations: Present in all cells of the body, inherited from a parent; account for ~10% of cancers (hereditary).

Clonal Origin and the Multi-Hit Model

Tumors are typically clonal, meaning all cells originate from a single progenitor cell that has accumulated multiple mutations in key cancer-causing genes. The multi-hit model states that several genetic alterations are required for a cell to become cancerous.

Environmental and Lifestyle Factors

Both genetic predisposition and environmental exposures contribute to cancer risk. Environmental factors such as chemicals, radiation, and infectious agents can act as mutagens and carcinogens, increasing mutation rates in the genome.

• Carcinogen: Any agent that causes cancer (e.g., tobacco, UV radiation, certain viruses and bacteria).

• Mutagen: An agent that increases the frequency of mutations.

Viruses and Bacteria in Cancer

Some cancers are associated with viral or bacterial infections. For example, human papillomavirus (HPV) is linked to cervical cancer, and Helicobacter pylori infection increases the risk of stomach cancer.

Hereditary Cancer Syndromes

Germline mutations in certain genes can greatly increase cancer risk. Examples include mutations in BRCA1 and BRCA2 (breast and ovarian cancer) and the RB1 gene (retinoblastoma).

Types of Genes Mutated in Cancer

Oncogenes

Oncogenes are mutated forms of normal genes (proto-oncogenes) that promote cell division. Gain-of-function mutations in these genes act dominantly; only one mutated copy is needed to drive cancer progression.

• Example: The Ras gene, which encodes a signaling protein, is mutated in about 30% of human tumors. A single point mutation (e.g., G12V) can cause Ras to remain active, continuously signaling the cell to divide.

Tumor Suppressor Genes

Tumor suppressor genes normally inhibit cell division or promote apoptosis. Loss-of-function mutations in these genes contribute to cancer in a recessive manner; both copies must be inactivated.

• Example: p53 is the most commonly mutated tumor suppressor gene in cancer, lost or mutated in about 55% of tumors. It acts as the "guardian of the genome," mediating DNA damage checkpoints and apoptosis.

DNA Repair Genes (Mutator Genes)

Genes involved in DNA repair, such as BRCA1, BRCA2, and those mutated in xeroderma pigmentosum (XP), are crucial for maintaining genomic integrity. Mutations in these genes lead to increased mutation rates and cancer susceptibility.

Telomerase and Immortalization

Normal somatic cells have a limited capacity to divide due to telomere shortening. Most cancer cells reactivate the telomerase gene, allowing them to divide indefinitely (immortalization).

Cellular Mechanisms and Checkpoints

Cell Cycle Checkpoints

Checkpoints in the cell cycle ensure that cells do not divide with damaged DNA. The p53 protein is central to these checkpoints, activating DNA repair or apoptosis in response to damage. Loss of checkpoint control leads to the accumulation of mutations and cancer progression.

Summary Table: Types of Genes Mutated in Cancer

Gene Type	Normal Function	Mutation Effect	Inheritance Pattern	Example
Oncogene	Promote cell division	Gain-of-function (overactive)	Dominant (one allele)	Ras
Tumor Suppressor	Inhibit cell division, promote apoptosis	Loss-of-function (inactive)	Recessive (both alleles)	p53, RB1
DNA Repair	Repair DNA damage	Loss-of-function (defective repair)	Recessive (both alleles)	BRCA1, BRCA2, XP genes
Telomerase	Maintain telomere length	Gain-of-function (immortalization)	Dominant (one allele)	TERT

Key Equations

• Probability of two independent mutations (Knudson's two-hit hypothesis):

$P = (1 \times 10^{-5}) \times (1 \times 10^{-5}) = 1 \times 10^{-10}$

• Probability if one allele is already mutated (hereditary):

$P = 1 \times 10^{-5}$

Conclusion

Cancer is fundamentally a genetic disease resulting from the accumulation of mutations in key regulatory genes. Both inherited and environmental factors contribute to cancer risk. Understanding the molecular and genetic basis of cancer is essential for developing effective prevention, diagnostic, and therapeutic strategies.